Seeking Alpha

Amgen (AMGN) might be set for a "Barron's bump" come Monday after Reshma Kapadia says the shares...

Amgen (AMGN) might be set for a "Barron's bump" come Monday after Reshma Kapadia says the shares may see a 20% upside just from "staying the course." Cited in the piece are CEO Robert Bradway's commitment to buybacks and dividends, cost cuts, a promising pipeline, and the shares' "sharp discount" to other large-cap biotechs.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|